Connection
Jesus Delgado-Calle to Proteasome Inhibitors
This is a "connection" page, showing publications Jesus Delgado-Calle has written about Proteasome Inhibitors.
|
|
Connection Strength |
|
|
|
|
|
0.055 |
|
|
|
-
Marino S, Petrusca DN, Bishop RT, Anderson JL, Sabol HM, Ashby C, Layer JH, Cesarano A, Dav? UP, Perna F, Delgado-Calle J, Chirgwin JM, Roodman GD. Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma. Haematologica. 2024 05 01; 109(5):1501-1513.
Score: 0.055